Qual é o impacto da terapia medicamentosa com agentes antirreabsortivos no sucesso dos implantes dentários? uma revisão de literatura
DOI:
https://doi.org/10.33448/rsd-v10i13.21074Palavras-chave:
Osteonecrose; Drogas antirreabsortivas; Bifosfonatos; Implante dentário; Taxa de sucesso.Resumo
Objetivo: Revisar a literatura atual e fornecer as informações mais recentes sobre osteonecrose dos maxilares induzida por agente antirreabsortivo (ARONJ), incluindo nossos achados de pesquisa básica e clínica, bem como discutir os riscos do desenvolvimento de osteonecrose em pacientes submetidos à cirurgia de implante dentário em uso de drogas antirreabsortivas (ARDs). Métodos: Foi realizada uma revisão de literatura utilizando artigos publicados nos periódicos indexados com base em banco de dados Pubmed, Web of Science, Embase e Scopus. Resultados: Nossos resultados mostram que a colocação de implantes dentários em pacientes tratados com ARDs deve ser avaliada com cautela, esses pacientes não são isentos de complicações e, portanto, a avaliação do risco deve ser feita de forma individualizada, pois uma das complicações mais graves, embora raras, é a ARONJ. Conclusão: Desse modo, todos os pacientes tratados com este tipo de medicamento devem ser informados sobre o risco de perda do implante ou da possibilidade de osteonecrose, sendo necessário informar do risco aumentado também os pacientes que já têm implantes osteointegrados e vão iniciar a terapia com bisfosfonatos (BPT). E, além disso, estabelecer uma relação e colaboração entre médico, dentista e paciente é essencial para o bom prognóstico desses casos.
Referências
Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons (2007). American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 65(3), 369–376. https://doi.org/10.1016/j.joms.2006.11.003
American Dental Association Council on Scientific Affairs (2006). Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. Journal of the American Dental Association (1939), 137(8), 1144–1150. https://doi.org/10.14219/jada.archive.2006.0355
Ata-Ali, J., Ata-Ali, F., Peñarrocha-Oltra, D., & Galindo-Moreno, P. (2016). What is the impact of bisphosphonate therapy upon dental implant survival? A systematic review and meta-analysis. Clinical oral implants research, 27(2), e38–e46. https://doi.org/10.1111/clr.12526
Baron, R., Ferrari, S., & Russell, R. G. (2011). Denosumab and bisphosphonates: different mechanisms of action and effects. Bone, 48(4), 677–692. https://doi.org/10.1016/j.bone.2010.11.020
Escobedo, M. F., Cobo, J. L., Junquera, S., Milla, J., Olay, S., & Junquera, L. M. (2020). Medication-related osteonecrosis of the jaw. Implant presence-triggered osteonecrosis: Case series and literature review. Journal of stomatology, oral and maxillofacial surgery, 121(1), 40–48. https://doi.org/10.1016/j.jormas.2019.04.012
Estrela, C. (2018). Metodologia Científica: Ciência, Ensino, Pesquisa (3ª edição). Editora Artes Médicas.
Ferreira, G. Z., Bachesk, A. B., Bachesk, A. B., Farah, G. J., Filho, L. I., Dos Santos Silva, R., Poluha, R. L., Danieletto-Zanna, C. F., & Gonçales, E. S. (2020). Oral Rehabilitation With Dental Implants and the Importance of a Preventive Evaluation for Osteonecrosis of the Jaws Associated With Medications. The Journal of oral implantology, 46(4), 431–437. https://doi.org/10.1563/aaid-joi-D-19-00275
Fugazzotto, P. A., Lightfoot, W. S., Jaffin, R., & Kumar, A. (2007). Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices. Journal of periodontology, 78(9), 1664–1669. https://doi.org/10.1902/jop.2007.060514
Gelazius, R., Poskevicius, L., Sakavicius, D., Grimuta, V., & Juodzbalys, G. (2018). Dental Implant Placement in Patients on Bisphosphonate Therapy: a Systematic Review. Journal of oral & maxillofacial research, 9(3), e2. https://doi.org/10.5037/jomr.2018.9302
Ghidini, G., Manfredi, M., Giovannacci, I., Mergoni, G., Sarraj, A., Mureddu, M., Giunta, G., Bonanini, M., Meleti, M., & Vescovi, P. (2017). Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs. Minerva stomatologica, 66(4), 135–140. https://doi.org/10.23736/S0026-4970.17.04056-0
Giovannacci, I., Meleti, M., Manfredi, M., Mortellaro, C., Greco Lucchina, A., Bonanini, M., & Vescovi, P. (2016). Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?. The Journal of craniofacial surgery, 27(3), 697–701. https://doi.org/10.1097/SCS.0000000000002564
Goss, A., Bartold, M., Sambrook, P., & Hawker, P. (2010). The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 68(2), 337–343. https://doi.org/10.1016/j.joms.2009.09.037
Granate-Marques, A., Polis-Yanes, C., Seminario-Amez, M., Jané-Salas, E., & López-López, J. (2019). Medication-related osteonecrosis of the jaw associated with implant and regenerative treatments: Systematic review. Medicina oral, patologia oral y cirugia bucal, 24(2), e195–e203. https://doi.org/10.4317/medoral.22691
Grant, B. T., Amenedo, C., Freeman, K., & Kraut, R. A. (2008). Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 66(2), 223–230. https://doi.org/10.1016/j.joms.2007.09.019
Guazzo, R., Sbricoli, L., Ricci, S., Bressan, E., Piattelli, A., & Iaculli, F. (2017). Medication-Related Osteonecrosis of the Jaw and Dental Implants Failures: A Systematic Review. The Journal of oral implantology, 43(1), 51–57. https://doi.org/10.1563/aaid-joi-16-00057
Ikebe, T. (2013). Pathophysiology of BRONJ: Drug-related osteoclastic disease of the jaw. Oral Science International,10:1-8.
Jacobsen, C., Metzler, P., Rössle, M., Obwegeser, J., Zemann, W., & Grätz, K. W. (2013). Osteopathology induced by bisphosphonates and dental implants: clinical observations. Clinical oral investigations, 17(1), 167–175. https://doi.org/10.1007/s00784-012-0708-2
Jeffcoat M. K. (2006). Safety of oral bisphosphonates: controlled studies on alveolar bone. The International journal of oral & maxillofacial implants, 21(3), 349–353.
Kasai, T., Pogrel, M. A., & Hossaini, M. (2009). The prognosis for dental implants placed in patients taking oral bisphosphonates. Journal of the California Dental Association, 37(1), 39–42.
Kunchur, R., Need, A., Hughes, T., & Goss, A. (2009). Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 67(6), 1167–1173. https://doi.org/10.1016/j.joms.2009.02.004
López-Cedrún, J. L., Sanromán, J. F., García, A., Peñarrocha, M., Feijoo, J. F., Limeres, J., & Diz, P. (2013). Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series. The British journal of oral & maxillofacial surgery, 51(8), 874–879. https://doi.org/10.1016/j.bjoms.2013.06.011
Marx R. E. (2003). Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 61(9), 1115–1117. https://doi.org/10.1016/s0278-2391(03)00720-1
Mücke, T., Krestan, C. R., Mitchell, D. A., Kirschke, J. S., & Wutzl, A. (2016). Bisphosphonate and Medication-Related Osteonecrosis of the Jaw: A Review. Seminars in musculoskeletal radiology, 20(3), 305–314. https://doi.org/10.1055/s-0036-1592367
Nisi, M., Izzetti, R., Gennai, S., Bellini, P., Graziani, F., & Gabriele, M. (2020). Surgical Management of Medication-Related Osteonecrosis of the Jaw Patients Related to Dental Implants. The Journal of craniofacial surgery, 31(4), 1037–1041. https://doi.org/10.1097/SCS.0000000000006283
Pichardo, S., van der Hee, J. G., Fiocco, M., Appelman-Dijkstra, N. M., & van Merkesteyn, J. (2020). Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ). The British journal of oral & maxillofacial surgery, 58(7), 771–776. https://doi.org/10.1016/j.bjoms.2020.03.022
Rawal, S.Y., Hilal, G. (2020). Osteonecrosis and spontaneous exfoliation of dental implants associated with oral bisphosphonate therapy: a case report. Aust Dent J, 65(1):100-103. doi:10.1111/adj.12738
Rodan, G.A., Reszka, A.A. (2002). Bisphosphonate mechanism of action. Curr Mol Med, 2(6):571-577. doi:10.2174/1566524023362104
Ruggiero, S. L., Dodson, T. B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B., O'Ryan, F., & American Association of Oral and Maxillofacial Surgeons. (2014). American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 72(10), 1938–1956. https://doi.org/10.1016/j.joms.2014.04.031
Ruggiero, S.L., Dodson, T.B., Assael, L.A., Landesberg, R., Marx, R.É., Mehrotra, B. (2009). American Association of Oral and Maxillofacial Surgeons. Artigo de posição da Associação Americana de Cirurgiões Bucais e Maxilofaciais sobre osteonecrose da mandíbula relacionada a bifosfonatos - atualização de 2009. J Oral Maxillofac Surg, 67: 2–12.
Shibahara T. (2019). Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone. The Tohoku journal of experimental medicine, 247(2), 75–86. https://doi.org/10.1620/tjem.247.75
Stavropoulos, A., Bertl, K., Pietschmann, P., Pandis, N., Schiødt, M., & Klinge, B. (2018). The effect of antiresorptive drugs on implant therapy: Systematic review and meta-analysis. Clinical oral implants research, 29 Suppl 18, 54–92. https://doi.org/10.1111/clr.13282
Stockmann, P., Nkenke, E., Englbrecht, M., Schlittenbauer, T., Wehrhan, F., Rauh, C., Beckmann, M. W., Fasching, P. A., Kreusch, T., Mackensen, A., Wullich, B., Schett, G., & Spriewald, B. M. (2013). Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jaw. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 41(1), 71–75. https://doi.org/10.1016/j.jcms.2012.10.018
Tam, Y., Kar, K., Nowzari, H., Cha, H. S., & Ahn, K. M. (2014). Osteonecrosis of the jaw after implant surgery in patients treated with bisphosphonates--a presentation of six consecutive cases. Clinical implant dentistry and related research, 16(5), 751–761. https://doi.org/10.1111/cid.12048
Vescovi P. (2012). Bisphosphonates and osteonecrosis: an open matter. Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases, 9(3), 142–144.
Vescovi, P., Merigo, E., Meleti, M., Manfredi, M., Guidotti, R., & Nammour, S. (2012). Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 41(3), 214–221. https://doi.org/10.1111/j.1600-0714.2011.01091.x
Yip, J. K., Borrell, L. N., Cho, S. C., Francisco, H., & Tarnow, D. P. (2012). Association between oral bisphosphonate use and dental implant failure among middle-aged women. Journal of clinical periodontology, 39(4), 408–414. https://doi.org/10.1111/j.1600-051X.2012.01854.x
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2021 Gabriela Sumie Yaguinuma Gonçalves; Leandro Marcel Soares Alves; Milena Steluti Marques
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Autores que publicam nesta revista concordam com os seguintes termos:
1) Autores mantém os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a Licença Creative Commons Attribution que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
2) Autores têm autorização para assumir contratos adicionais separadamente, para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.
3) Autores têm permissão e são estimulados a publicar e distribuir seu trabalho online (ex.: em repositórios institucionais ou na sua página pessoal) a qualquer ponto antes ou durante o processo editorial, já que isso pode gerar alterações produtivas, bem como aumentar o impacto e a citação do trabalho publicado.
